Happy elderly couple in fun fair.

Driving innovation for the multiple myeloma community

Target the Future is a global, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community. The programme provides education on progress in the field of multiple myeloma, identifies key challenges the community faces, and facilitates solutions to create a better future for patients, their caregivers and loved ones.

The programme’s Think Tank Challenge issues an annual call for entries for ideas to create a better future for the multiple myeloma community. Funding of £70,000 (approximately $100,000) is awarded to the strongest proposal to help bring the idea to life.

Target the Future Think Tank Challenge 2022 Winner

Congratulations to the inaugural winner of the Target the Future Think Tank Challenge – the HealthTree Equity and Diversity for Multiple Myeloma Program!

The programme focuses on broadening reach to educate and support myeloma patients and ensure all patients are given equal opportunity for excellent care, by:

  • Helping patients understand their treatment options, including clinical trials
  • Aiding patients in the search for a multiple myeloma specialist
  • Supporting patients emotionally (via one-on-one sessions and in groups)
  • Addressing disparities for key ethnic groups (African Americans and Hispanics) and other underserved communities

“I’m a myeloma patient myself and am passionate about supporting my multiple myeloma peers. The key challenge is no longer that programs don’t exist – it’s that patients are not aware of the amazing support that is available,” said Jenny Ahlstrom, HealthTree Founder and CEO and Think Tank Challenge winner.

GSK wishes to express its gratitude for the more than 20 novel Think Tank Challenge entries from around the world, which proposed solutions to finding the right care, addressing disparities and supporting the emotional burden of patients living with multiple myeloma. The call for entries for the next Think Tank Challenge will be issued in fall 2022.

Key facts about Target the Future

Target the Future goes beyond the science

The programme strives to address unmet needs and aims to improve the lives of patients living with multiple myeloma.

Target the Future is a global, multi-year programme

The Think Tank Challenge attracted more than 20 global entries in its inaugural year; the next call for entries will be issued in fall 2022.

GSK awards £70,000 (approximately $100,000) annually to Think Tank Challenge winners

Awardees can leverage grant funding to accelerate innovation and bring their winning ideas to life.

Target the Future updates

GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community

Target the Future in the news

  • My Myeloma Team | 01/18/2022

    How would you use $100,000 to improve myeloma care?

    visit >
  • MM+M | 01/10/2022

    GSK crowdsources multiple myeloma innovation in new program

    visit >